Skip to search formSkip to main contentSkip to account menu

ilepatril

Known as: (4S,7S,12BR)-7-((2S)-2-(Acetylsulfanyl)-3-Methylbutanamido)-6-Oxo-1,2,3,4,6,7,8,12b-Octahydropyrido(2,1-A)(2)Benzazepine-4-Carboxylic Acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract Objective: The aim of the present study was to compare the preventive impact of treatment with a vasopeptidase inhibitor… 
Highly Cited
2012
Highly Cited
2012
PURPOSE Cornea confocal microscopy is emerging as a clinical tool to evaluate the development and progression of diabetic… 
2012
2012
We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural… 
2012
2012
  • N. Efron
  • Investigative ophthalmology & visual science
  • 2012
  • Corpus ID: 11779516
N europathy is a frequent complication of diabetes and is a major cause of morbidity and mortality, potentially affecting distal… 
Review
2008
Review
2008
  • R. Tabrizchi
  • Current opinion in investigational drugs
  • 2008
  • Corpus ID: 11705565
sanofi-aventis (formerly Aventis Pharma AG) is developing ilepatril (AVE-7688), a dual angiotensin-converting enzyme and neutral…